Published on 1 Mar 2024 on FOX 23 News Albany
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an...
NASDAQ.SNDX price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free